Skip to main content
Caplight Logo









CiVi Biopharma

CiVi Biopharma

Private
Chevy Chase, MarylandHealthcare & Life Scienceshttps://www.civibio.com/

Last Round

VC Round

Dec 15, 2020

Total Funding Raised

$120M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

CiVi Biopharma is a biotechnology company that develops novel cardiovascular and metabolic therapies for patients with unmet medical needs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverycardiovascular therapyoral delivery platformoligonucleotide therapeuticsPCSK9 inhibitorclinical-stage biotechmetabolic diseasedrug out-licensingbiopharma licensinglipid disordersdrug pipelinebiotech startuppharma partnering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CiVi Biopharma Comparables

Compare CiVi Biopharma with similar companies based on industry and business-model similarity.

CiVi Biopharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ELEO Inc.
85%
Shifa Biomedical Corporation
85%
Aqur Biosciences, Inc.
84%

CiVi Biopharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 15, 2020
Series AJan 5, 2017

CiVi Biopharma Investors

Notable investors and investment history

CiVi Biopharma investors
InvestorRounds
RA Capital ManagementVC Round, Early Funding
Boxer CapitalVC Round, Series A
Roche Venture FundEarly Funding
Tavistock GroupSeries A
Boxer CapitalEarly Funding, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 76% MoM.

  • Dec 15, 2020

    $28M round with Boxer Capital and RA Capital Management.

CiVi Biopharma Filings

Explore SEC and related filing metadata, where available.

CiVi Biopharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CiVi Biopharma's valuation, stock price, and market status.

Is CiVi Biopharma a public or private company?

CiVi Biopharma is a private company.

What is the current stock price of CiVi Biopharma?

CiVi Biopharma is a private company with no public stock price. No recent secondary market data is available.

How much is CiVi Biopharma worth (valuation)?

Valuation information for CiVi Biopharma is not publicly available.

Can I buy CiVi Biopharma stock?

CiVi Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CiVi Biopharma's last funding round?

CiVi Biopharma's most recent funding round was Series A on January 5, 2017.

Who are the main investors in CiVi Biopharma?

Key investors in CiVi Biopharma include Boxer Capital.

Will CiVi Biopharma IPO soon?

No public IPO plans have been announced for CiVi Biopharma.

How can I track CiVi Biopharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CiVi Biopharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersChevy Chase, Maryland
Employee Range7
Year Founded2016
Last FundingDec 15, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?